Best Microtubule Inhibitor for liposarcoma
The 2 Microtubule Inhibitor options we list for liposarcoma are all Eribulin Mesylate— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for liposarcoma or the full Microtubule Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 microtubule inhibitor drugs we rate for liposarcoma, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for liposarcoma; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for liposarcoma
These are all Eribulin Mesylatein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 microtubule inhibitor products
eribulin mesylate
PrescriptionFDA-sourced
Eribulin Mesylate is a microtubule inhibitor used to treat Breast Neoplasms, Liposarcoma.
Price varies
halaven
PrescriptionFDA-sourced
Halaven (Eribulin Mesylate) is a microtubule inhibitor used to treat Breast Neoplasms, Liposarcoma.
Price varies
Frequently asked
- What is the best microtubule inhibitor for liposarcoma?
- The Microtubule Inhibitor options we list for liposarcoma are all Eribulin Mesylate — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which microtubule inhibitor drugs treat liposarcoma?
- pharmaranks lists 2 Microtubule Inhibitor products used for liposarcoma, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.